Product Research and Development
Cooperation
Cooperation
CGeneTech (Suzhou, China) Co., Ltd. is dedicated to the development and industrialization of small molecule innovative drugs for breakthrough therapies. With its integrated drug discovery technology platform and diversified business vision, the company has built a rich pipeline of innovative drugs covering various disease areas such as hypoglycemia, anti-cancer and rare diseases. Among them, Shengliptin phosphate is expected to fill the gap of the original DPP-4 inhibitor in China, while the first generic drug for the treatment of rare disease multiple sclerosis, Teriflunomide tablets, has also been approved for marketing. In the future, the Company will focus on unmet clinical needs in China and around the world to develop innovative drugs with high patient accessibility and better efficacy to benefit patients worldwide.
We are actively looking for global partners, feel free to contact us!
Tel：+86 18013170489
E-mail：panhp@cgenetech.com.cn
Contact Information
Address: Room 101, Bld C11, 218 Xinghu Rd,Suzhou industrial Park,China, 215123
Tel： +86-512-62956960（Recruitment）
+86-512-62956961（marketing）
Copyright © 2022 CGeneTech (Suzhou, China) Co., Ltd.
在线客服添加返回顶部
页面顺滑的滚动
屏蔽页面上图片的alt/title提示
右侧在线客服样式 1,2,3 2
图片alt标题设置： Fland Environmental
表单验证提示文本： The content cannot be empty!
循环体没有内容时： Content is being organized—please wait!
CSS / JS 文件放置地